Century Therapeutics, Inc.

NasdaqGS IPSC

Century Therapeutics, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2024: USD 198.11 M

Century Therapeutics, Inc. Cash and Short-Term Investments is USD 198.11 M for the quarter ending September 30, 2024, a 16.88% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Century Therapeutics, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2023 was USD 169.50 M, a -52.37% change year over year.
Century Therapeutics, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2022 was USD 355.86 M, a 20.57% change year over year.
Century Therapeutics, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2021 was USD 295.15 M.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

NasdaqGS: IPSC

Century Therapeutics, Inc.

CEO	Mr. Brent Pfeiffenberger M.B.A., Pharm.D.
IPO Date	June 18, 2021
Location	United States
Headquarters	3675 Market Street
Employees	152
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Key trends

Past 5 years